Pulse Biosciences, Inc. (PLSE)
47.47
+3.04
(+6.84%)
USD |
NASDAQ |
Oct 19, 16:00
47.47
0.00 (0.00%)
After-Hours: 20:00
Pulse Biosciences Cash from Operations (Annual) : -54.12M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -54.12M |
| December 31, 2024 | -36.34M |
| December 31, 2023 | -33.04M |
| December 31, 2022 | -47.01M |
| December 31, 2021 | -54.10M |
| December 31, 2020 | -35.36M |
| Date | Value |
|---|---|
| December 31, 2019 | -34.18M |
| December 31, 2018 | -23.90M |
| December 31, 2017 | -11.09M |
| December 31, 2016 | -8.051M |
| December 31, 2015 | -3.317M |
| December 31, 2014 | -0.1016M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Accuray, Inc. | -6.981M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 33.35M |
| ResMed, Inc. | 1.806B |
| Rockwell Medical, Inc. | -0.659M |